ATE330028T1 - Verwendung eines prostatatumor auslösenden gens zum aufspüren von krebszellen - Google Patents
Verwendung eines prostatatumor auslösenden gens zum aufspüren von krebszellenInfo
- Publication number
- ATE330028T1 ATE330028T1 AT97939816T AT97939816T ATE330028T1 AT E330028 T1 ATE330028 T1 AT E330028T1 AT 97939816 T AT97939816 T AT 97939816T AT 97939816 T AT97939816 T AT 97939816T AT E330028 T1 ATE330028 T1 AT E330028T1
- Authority
- AT
- Austria
- Prior art keywords
- pti
- cancer cells
- protein
- sample
- measuring
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 208000023958 prostate neoplasm Diseases 0.000 title abstract 3
- PCNLLVFKBKMRDB-UHFFFAOYSA-N N-ethyl-N-[[2-(1-pentylindol-3-yl)-1,3-thiazol-4-yl]methyl]ethanamine Chemical compound C(C)N(CC=1N=C(SC=1)C1=CN(C2=CC=CC=C12)CCCCC)CC PCNLLVFKBKMRDB-UHFFFAOYSA-N 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 2
- 108020004999 messenger RNA Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003757 reverse transcription PCR Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70820896A | 1996-09-06 | 1996-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE330028T1 true ATE330028T1 (de) | 2006-07-15 |
Family
ID=24844826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97939816T ATE330028T1 (de) | 1996-09-06 | 1997-09-05 | Verwendung eines prostatatumor auslösenden gens zum aufspüren von krebszellen |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0951567B1 (de) |
| AT (1) | ATE330028T1 (de) |
| AU (1) | AU4182697A (de) |
| DE (1) | DE69736122T2 (de) |
| WO (1) | WO1998010098A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998024935A1 (en) * | 1996-12-06 | 1998-06-11 | Urocor, Inc. | Diagnosis of disease state using mrna profiles |
| US7332270B1 (en) | 1997-03-24 | 2008-02-19 | Urocor, Inc. | Diagnosis of disease state using mRNA profiles in peripheral leukocytes |
| EP1100903A1 (de) * | 1998-07-24 | 2001-05-23 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Pb 39, ein dysreguliertes gen in prostatakrebs und deren verwendung |
| US7226731B1 (en) | 1998-07-24 | 2007-06-05 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | PB 39, a gene dysregulated in prostate cancer, and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5851764A (en) * | 1990-10-25 | 1998-12-22 | The Trustees Of Columbia University In The City Of New York | Human prostate tumor inducing gene-1 and uses thereof |
-
1997
- 1997-09-05 EP EP97939816A patent/EP0951567B1/de not_active Expired - Lifetime
- 1997-09-05 AU AU41826/97A patent/AU4182697A/en not_active Abandoned
- 1997-09-05 WO PCT/US1997/015645 patent/WO1998010098A1/en not_active Ceased
- 1997-09-05 DE DE69736122T patent/DE69736122T2/de not_active Expired - Fee Related
- 1997-09-05 AT AT97939816T patent/ATE330028T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0951567A1 (de) | 1999-10-27 |
| DE69736122T2 (de) | 2007-01-04 |
| AU4182697A (en) | 1998-03-26 |
| EP0951567A4 (de) | 2002-10-16 |
| EP0951567B1 (de) | 2006-06-14 |
| DE69736122D1 (de) | 2006-07-27 |
| WO1998010098A1 (en) | 1998-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL181132A0 (en) | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system | |
| ATE215993T1 (de) | Nachweis von nukleinsäuren mit breitem dynamikbereich unter verwendung von aggregat- primer-reihen | |
| DE60226271D1 (de) | Verfahren zum nachweis von prostatakrebs | |
| DK463089D0 (da) | Fremgangsmaade og reagenssaet til detektion af en specifik nucleinsyresekvens i en proeve indeholdende en nucleinsyre | |
| ES2170220T3 (es) | Procedimiento para detectar sustancias biologicamente activas. | |
| ATE408829T1 (de) | Verfahren und assaykits zum nachweis mononuklearer zellphänotypen | |
| ES2101116T3 (es) | Metodo de deteccion de una secuencia de acidos nucleicos. | |
| ATE326550T1 (de) | Quantitative methode zum nachweis der nukleotidkonzentration | |
| ATE330028T1 (de) | Verwendung eines prostatatumor auslösenden gens zum aufspüren von krebszellen | |
| ATE184055T1 (de) | Verfahren zum sensitiven nachweis von reverser transcriptase | |
| ATE480774T1 (de) | Verfahren und proben zur detektion des tumor spezifische fusion proteinen | |
| ATE158344T1 (de) | Verfahren zum nachweis der differenzierung und der invasivität von karzinomzellen | |
| WO2002063048B1 (en) | Methods for predicting sensitivity of tumors to arginine deprivation | |
| IL189185A0 (en) | Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system | |
| SE0202702L (sv) | Immunotest för specifik bestämning av SCCA isoformer | |
| WO1999006831A3 (en) | Breast cancer resistance genes, methods for their detection and uses thereof | |
| DK1416278T3 (da) | Fremgangsmåder til forbedret diagnosticering af dysplasier | |
| CN121802023A (zh) | 一种基于CRISPR/Cas12a的大豆内源基因测试剂盒、检测方法及用途 | |
| WO2001098530A3 (en) | Interaction of tbx2 and the arf promoter in cell cycle regulator assays | |
| DK200100932A (da) | Fremgangsmåde til fremstilling af et reagens bestående af et antigenisk oligopeptid | |
| DK200100931A (da) | Fremgangsmåde til isolering af humane celler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |